North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach $10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.
Highlighted with 23 tables and 49 figures, this 103-page report “North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Consumables
• Sequencers & Software
• Service
Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Diagnostics
o Oncology
o Reproductive Health
o Complex Disease Research
o Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
